Clinical Trial

ProVIDE II Bridging Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-01-24; most recent amendment 2026-07-07.
Status change: Enrolling by Invitation → Active, Not Recruiting 2024-09-17
Status change: Recruiting → Enrolling by Invitation 2024-07-05
Status change: Not Yet Recruiting → Recruiting 2024-05-03
Trial Details
NCT Number NCT06236802
Lead Sponsor ProVerum Medical
Conditions BPH With Symptomatic Lower Urinary Tract Symptoms
Enrollment 40 participants
Start Date 2024-03-06
Primary Completion 2024-09-06 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-09